Effect of an isolated active compound (Cg-1) of Cassia glauca leaf on blood glucose, lipid profile, and atherogenic index in diabetic rats

• Published in: Indian journal of pharmacology 2009-07, Vol.41 (4), p.182-186
• Main Authors: Mazumder, Papiya Mitra, Farswan, Mamta, Parcha, V
• Format: Article
• Language: English
• Subjects: Beans; Blood glucose, β-sitosterol, Cassia glauca, diabetes, lipid profile, streptozotocin; Care and treatment; Diabetes; Glucose; Health aspects; Hyperglycemia; Legumes; Medicinal plants; Mimosaceae; Polyphenols; Properties; Rodents
• ISSN: 0253-7613; 1998-3751
• DOI: 10.4103/0253-7613.56076

Objectives: The objective of present study was to evaluate the effect of active principle (Cg-1) from Cassia glauca leaf on serum glucose and lipid profile in normal and diabetic rats. Materials and Methods: Diabetes was induced by streptozotocin in neonates. Oral administration of petroleum ether, chloroform, acetone, and methanol of C. glauca leaf (100 mg/kg, p.o.) for 21 days caused a decrease in fasting blood glucose (FBG) in diabetic rats. Among all the extracts, acetone extract was found to lower the FBG level significantly in diabetic rats. Glibenclamide was used as standard antidiabetic drug (5 mg/kg, p.o). Acetone extract was subjected to column chromatography that led to isolation of an active principle, which was given trivial name Cg-1. Cg-1 (50 mg/kg, p.o.) was studied for its hypoglycemic and hypolipidemic potential. The unpaired t-test and analysis of variance (ANOVA) followed by post hoc test was used for statistical analysis. Results: Cg-1 caused a significant reduction in FBG level. It also caused reduction in cholesterol, triglycerides, and LDL levels and improvement in the atherogenic index and HDL level in diabetic rats. Conclusion: Improvement in the FBG and the atherogenic index by Cg-1 indicates that Cg-1 has cardioprotective potential along with antidiabetic activity and provides a scientific rationale for the use as an antidiabetic agent.